Sangair AB
559080-3317ActiveDeveloping revolutionary blood treatment technology to combat severe sepsis infections.
Biotechnology Companysangair.se
Overview
- 5–9
- Employees
- 1–49K SEK
- Revenue
- 2016
- Founded
Key Decision Makers
Johan Sjöholm
Board Member, Founder
Henrik Rundgren
Board member
Martin Wiklund
Board member
Sara Weman
Engineer
+2 more contacts in Funnelfeedr
Description
Sangair AB is a Swedish biotechnology company focused on developing innovative solutions for critical medical conditions. Their core innovation is SangAsept, a unique process designed to treat blood extracorporeally, meaning outside the body. This technology immediately targets and reduces harmful b...